Avidity Biosciences, Inc.
RNA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$322,302 | -$212,220 | -$173,995 | -$118,009 |
| Dep. & Amort. | $2,776 | $2,101 | $1,387 | $639 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $51,363 | $38,222 | $27,139 | $17,056 |
| Change in WC | -$14,557 | $61,129 | $9,816 | $5,338 |
| Other Non-Cash | -$18,150 | -$8,296 | -$615 | $163 |
| Operating Cash Flow | -$300,870 | -$119,064 | -$136,268 | -$94,813 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$7,066 | -$4,228 | -$2,823 | -$3,740 |
| Net Acquisitions | $0 | $0 | $187,132 | $82,517 |
| Inv. Purchases | -$1,433,535 | -$461,002 | -$355,837 | -$85,357 |
| Inv. Sales/Matur. | $586,400 | $335,160 | $168,705 | $6,580 |
| Other Inv. Act. | $0 | $0 | -$187,132 | -$82,517 |
| Investing Cash Flow | -$854,201 | -$130,070 | -$189,955 | -$82,517 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $1,000,549 | $60,547 | $344,779 | $174,677 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $191,808 | $33,317 | $1,392 | $1,639 |
| Financing Cash Flow | $1,192,357 | $93,864 | $346,171 | $176,316 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $37,286 | -$155,270 | $19,948 | -$1,014 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $185,377 | $340,647 | $320,699 | $321,713 |
| End Cash | $222,663 | $185,377 | $340,647 | $320,699 |
| Free Cash Flow | -$307,936 | -$123,292 | -$139,091 | -$98,553 |